New Cancer Drugs Aren't Always a Good Idea

Just over five years ago, Gardiner Harris wrote a profile of Dr. Richard Pazdur for the New York Times. Pazdur was—and still is—the man in charge of approving or disapproving new cancer drugs at the FDA: unless and until he approves it, you’re not allowed to prescribe it. And the NYT didn’t go easy on him: the headline was “Where Cancer Progress Is Rare, One Man Says No.”